Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: determined (252), resolute (3)

DVd(Twice weekly)Daratumumab-Bortezomib-Dexamethasone Cycle 9 onwards

Description: Chemotherapy Protocol Myeloma Bortezomib (twice weekly) Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myeloma – Bortezomib (twice weekly) with daratumumab and dexamethasone Note
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdTwice-weeklyDaratumumab-Bortezomib-Dexamethasone-Cycle-9-onwards.pdf

Hydration Pilots application and support pack process

Description: January Classification: Official Hydration Pilots: Application support pack & process Hydration Pilots: application support pack and process 1.0 Aim The NH
Url: /Media/Southampton-Clinical-Research/Grants/Download/Hydration-Pilots-application-and-support-pack-process.docx

E(100)CT

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN (100) Regimen (E100CT) • Breast Cancer – Cyclophosphamide-Docetaxel-Epirubicin (100) (E100CT) Indication • Neo-adjuvant / adjuvant
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/E100CT.pdf

Cyclophosphamide-Docetaxel-Epirubicin (100)-Fluorouracil (FE100CT)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN (100)- FLUOROURACIL Regimen (FE100CT) • Breast Cancer – Cyclophosphamide-Docetaxel-Epirubicin (100)-Fluorouracil (FE100CT) Indication • Neo
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Docetaxel-Epirubicin-100-Fluorouracil.pdf

Pulmonary vein isolation radiofrequency ablation - patient information

Description: Patient information factsheet Pulmonary vein isolation (PVI) ablation Your doctor has recommended you have the above procedure. This factsheet has been
Url: /Media/UHS-website-2019/Patientinformation/Heartandlungs/Pulmonaryveinisolationradiofrequencyablation-725-PIL.pdf

Liver enhanced recovery - patient information

Description: What to expect in the days before and after your liver resection operation and introducing our liver enhanced recovery programme (ERP
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Liver-enhanced-recovery-2257-PIL.pdf

VR-RituximabVenetoclax Cycle_2 Onwards

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) (Cycle 2 onwards) Regimen • CLL – VR Rituxi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclax-Cycle-2-Onwards.pdf

RFC_PO

Description: Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA RFC-CYCLOPHOSPHAMIDE-FLUDARABINE-RITUXIMAB (PO) Regimen • CLL – RFC (PO)-C
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/RFC-PO.pdf

RFC_PO_Split

Description: Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA CYCLOPHOSPHAMIDE-FLUDARABINE-RITUXIMAB (PO-Split) Regimen • CLL – RFC (PO)
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/RFC-PO-Split.pdf

RFC_IV

Description: Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA CYCLOPHOSPHAMIDE-FLUDARABINE-RITUXIMAB (IV) Regimen • CLL – RFC (IV)-Cyclo
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/RFC-IV.pdf

451 to 460 of 496

Previous … 44 45 46 47 48 … Next